Brittle cornea syndrome (BCS) is a rare autosomal recessive connective tissue disorder characterised by severe corneal thinning, with the major ocular risk being spontaneous ocular perforation due to progressive stromal thinning and ectasia. It is a complex condition with limited treatment options. The purpose of this review is to highlight the difficulties associated with the condition and examine the available published evidence with regards to management.
CITATION STYLE
Walkden, A., Burkitt-Wright, E., & Au, L. (2019). Brittle cornea syndrome: Current perspectives. Clinical Ophthalmology, 13, 1511–1516. https://doi.org/10.2147/OPTH.S185287
Mendeley helps you to discover research relevant for your work.